ChemoCentryx Reports Second Quarter 2020 Financial Results and Recent Highlights

NEXT STORY
Calithera Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights
PREV STORY
Novavax Reports Second Quarter 2020 Financial and Operational Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Merus’ Intellectual Property Portfolio Expands with Two New Patents

UTRECHT, The Netherlands, March 13, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage ...

author_avatar
NASDAQ Market News

Horizon Pharma plc Selected as One of Chicago’s Top Workplaces by the Chicago Tribune

DUBLIN, Ireland, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP) a biopharmaceutical company ...

author_avatar
NASDAQ Market News

Progenics Acquires AZEDRA® (iobenguane I 131) Radiopharmaceutical Manufacturing Facility

NEW YORK, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology ...

author_avatar
NASDAQ Market News